Vitamina D. Consenso colombiano de expertos

Autores/as

  • David Vásquez-Awad Academia Nacional de Medicina
  • Carlos Alberto Cano-Gutiérrez Pontificia Universidad Javeriana
  • Armando Gómez-Ortiz Centro Médico Almirante Colón
  • Miguel Ángel González Asociación Colombiana de Osteoporosis y Metabolismo Mineral (ACOMM)
  • Renato Guzmán-Moreno Fundación Universitaria Juan N. Corpas.
  • José Ignacio Martínez-Reyes Clínica Los Nogales
  • Oscar Rosero-Olarte Osteollanos Centro de investigación en Osteoporosis
  • Camilo Rueda-Beltz Universidad de la Sabana
  • Jorge Luis Acosta-Reyes Universidad del Norte. Barranquilla, Colombia

Palabras clave:

Vitamina D, osteoporosis, menopausia, osteomalacia, masa ósea, fracturas por fragilidad, Vitamin D, menopause, bone mass, fragility fractures

Resumen

La Vitamina D ha adquirido importancia no solo por su conocido papel en el mantenimiento de la masa ósea, sino por la evidencia reciente que vincula su deficiencia con patologías cardiovasculares, metabólicas, gineco-obstétricas, oncológicas e infecciosas entre otras. Se han considerado normales niveles por encima de 30 ng/mL y hay una relación inversamente proporcional entre los niveles de Vitamina D y la presencia de patologías diversas, entre las cuales se destacan las osteomusculares que ofrecen más contundencia de la relación en la evidencia.

Por eso, la evaluación de los niveles de Vitamina D en población de alto riesgo y el tratamiento de la hipovitaminosis constituyen medidas que el personal de salud debe realizar. La identificación de esta población y la revisión de los esquemas de suplementación representan los objetivos primordiales de este consenso. En forma de sugerencias y recomendaciones, pensando en el impacto que el documento pueda tener en la salud pública, se presenta el Consenso colombiano de Vitamina D que contó con la participación de especialistas de siete ramas de la medicina y la implementación de la técnica Delphi, técnica mundialmente aceptada para este tipo de ejercicios académicos.

 

Vitamin D Colombian expert consensus

Abstract

Vitamin D has been gaining importance not only because of its role in bone mass preservation but for recent evidence that links its deficiency with cardiovascular, metabolic, oncologic, infectious, gynecological, and obstetric pathologies, among others. Levels above 30 ng/mL are considered normal, and there are inverse relationship levels of vitamin D and the presence of diverse pathologies, being the musculoskeletal the ones concentrating much of the attention and presenting the most convincing evidence.

The health staff must carry out measurements such as evaluating vitamin D levels in high-risk population and treat hypovitaminosis. The paramount objectives of this consensus are to identify this population and revise the supplementation schemes. The Colombian Consensus on Vitamin D is presented as suggestions and recommendations, keeping in mind the possible impact of this paper on public health, with the participation of specialists from seven different branches of medicine, and using the Delphi technique, worldly accepted for these kinds of academic exercises.

Biografía del autor/a

David Vásquez-Awad, Academia Nacional de Medicina

MD., Esp. Ginecología y obstetricia, Epidemiología, Densitometría clínica (ISCD) y Seguridad Social. Miembro honorario, Asociación Colombiana de Menopausia. Miembro del Consejo, Facultad de Medicina de la Pontificia Universidad Javeriana. Miembro de Número y Secretario General, Academia Nacional de Medicina de Colombia. Bogotá, Colombia.

Carlos Alberto Cano-Gutiérrez, Pontificia Universidad Javeriana

MD., Esp. Geriatría. Director del Instituto de envejecimiento, Pontificia Universidad Javeriana. Jefe de la Unidad de Geriatría, Hospital Universitario San Ignacio. Bogotá, Colombia.

Armando Gómez-Ortiz, Centro Médico Almirante Colón

MD., Esp. Medicina interna, Esp. Cardiología no invasiva. Director del Servicio de Cardiología no Invasiva y Cardiología Clínica, Centro Médico Almirante Colón. Profesor asociado, Universidad El Bosque. Bogotá, Colombia.

Miguel Ángel González, Asociación Colombiana de Osteoporosis y Metabolismo Mineral (ACOMM)

MD., Esp. Ortopedia y traumatología, Esp. Ortopedia Geriátrica. Secretario y Tesorero, Asociación Colombiana de Osteoporosis y Metabolismo Mineral (ACOMM). Presidente del Capítulo de Tumores Óseos y Enfermedades Metabólicas, Sociedad Colombiana de Cirugía Ortopédica y Traumatología (SCCOT). Bogotá, Colombia.

Renato Guzmán-Moreno, Fundación Universitaria Juan N. Corpas.

MD., Esp. Medicina interna, Esp. Reumatología. Investigador clínico. Profesor titular de Inmunología y Medicina Interna, Fundación Universitaria Juan N. Corpas. Director científico, Instituto de enfermedades autoinmunes Renato Guzmán (IDEARG). Bogotá, Colombia.

José Ignacio Martínez-Reyes, Clínica Los Nogales

MD., Esp. Medicina interna, Esp. Oncología. Jefe de Oncología, Clínica Los Nogales. Oncólogo, Hospital Central de la Policía Nacional. Médico asesor nacional de Oncología, EPS Coomeva. Bogotá, Colombia.

Oscar Rosero-Olarte, Osteollanos Centro de investigación en Osteoporosis

MD., Esp. Medicina interna, Densitometría clínico (ISCD) y Endocrinología. Director Médico, Osteollanos Centro de investigación en Osteoporosis. Villavicencio, Colombia.

Camilo Rueda-Beltz, Universidad de la Sabana

MD., Esp. Ginecología y obstetricia, Esp. Menopausia. Profesor Clínico y Miembro del grupo de Investigación en Salud Sexual y Procreativa, Universidad de la Sabana. Representante de Colombia ante IMS-CAMS. Bogotá, Colombia.

Jorge Luis Acosta-Reyes, Universidad del Norte. Barranquilla, Colombia

MD., MSc. Epidemiología clínica. Profesor, Universidad del Norte. Barranquilla, Colombia.

Referencias bibliográficas

Varela-Ruiz M., Díaz-Bravo L, García-Durán R. Descripción y usos del método Delphi en investigaciones del área de la salud. Inv Ed Med. 2012; 1 (2): 90- 95.

Cabero J, e Infante A. Empleo del método Delphi y su empleo en la investigación en comunicación y educación. Edutec-e. 2014; 48: 1- 16. Disponible en: http://edutec.rediris.es/Revelec2/Revelec48/n48_Cabero_Infante.html

Somerville J.A. Effective Use of the Delphi Process in Research: Its Characteristics, Strengths and Limitations. Estados Unidos: Oregon State Unversity: 2008; 11 pp. Disponible en: http://jasomerville.com/wp-content/uploads/2011/08/DelphiProcess080617b.pdf

Iglesias A. Historia de la Vitamina D. 1a Ed. Barranquilla: Universidad Simon Bolívar: 2008.

Holick MF. Vitamin D: Photobiology, metabolism, mechanism of action, and clinical applications. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Washington: American society for Bone and Mineral Research: 2003; 129-137 pp.

Vásquez-Awad D. Vitamina D y su importancia en la Salud Humana. Medicina. 2013; 35 (3): 214- 226.

Vásquez-Awad D, Guzmán R. Osteoporosis: enfoque clínico y tratamiento. 1a Ed. Bogotá: Kimpres; 2012. Capítulo: Vitamina D: actualización; 496- 527.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011; 96 (7): 1911- 1930.

Holick MF, Chen TC. Vitamin D deficiency: A world- wide problem with health consequences. Am. J. Clin. Nutr. 2008; 87 (4): 1080S- 1086S.

Cianferotti L, Cricelli C, Kanis JA, Nuti R, Reginster JYRizzoli R, et al. The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Endocrine. 2015; 50 (1): 12- 26.

Guzmán-Moreno RA, Piñeros LG, Teheran A, Flechas J, Mejía M. Hypovitaminosis D and calcium intake of adult population in Bogota. (DICAVITD). Ann Rheum Dis. 2016; 75 (2).

Hormaza MP, Cuesta D, Martínez LM, Massaro MM, Campo MN, Vélez MP et al. Niveles séricos de 25 hidroxivitamina D en mujeres no menopáusicas, menopáusicas y posmenopáusicas. Rev Colomb Obstet Ginecol. 2011; 62 (3): 231- 236.

Molina JF, Molina J, Escobar JA, Betancur JF, Giraldo A. Niveles de 25 hidroxivitamina D y su correlación clínica con diferentes variables metabólicas y cardiovasculares en una población de mujeres posmenopáusicas. Acta Med Colomb. 2011; 36 (1): 18- 23.

González D, Zúñiga C, Kattah W. Insuficiencia de vitamina D en pacientes adultos con baja masa ósea y osteoporosis en la Fundación Santa Fe de Bogotá 2008-2009. Rev Col Reumatol. 2010; 17 (4): 212- 218.

Rosero O, Rueda V, Sosa M, Ospina J. Deficiencia de Vitamina D en mujeres post menopaúsicas con baja masa ósea en Villavicencio. Colombia. 13° Congreso Colombiano de Endocrinología. 2015, abril 23- 26; Colombia.

Rosero O, Rueda V, Ospina JM. Masa ósea reducida e hipo-vitaminosis D en mujeres posmenopáusicas: estudio exploratorio en Villavicencio, Colombia. 2012- 2013. Arch Med (Manizales). 2015; 15 (1): 46- 56.

Guzman Moreno RA, Piñeros LG, Teheran A, et al. Calcium intake of adult population in Bogota and association with hypovitaminosis D. Next step: The same analysis in 100 patients with Systemic Lupus Erythematosus. Clin Exper Rheumatol. Supl.

Wedad Z, Mostafa WZ. Vitamin D and the skin: Focus on a complex relationship: A review. J Adv Res. 2015; 6 (6): 793- 804.

Stalgis-Bilinski K, Boyages J, Salisbury E, Dunstan C, Henderson S, Talbot P. Burning daylight: balancing vitamin D requirements with sensible sun exposure. Med J Aust. 2011; 194 (7): 345- 348.

Diehl JW, Chiu MW. Effects of ambient Sunlight and Photoprotection on Vitamin D Status. Dermatol Ther. 2010; 23 (11): 48- 60.

Hartley M, Hoare S, Lithander FE, Neale RE, Hart PH, Goran S, et. al. Comparing the effects of sun exposure and vitamin D supplementation on vitamin D insufficiency, and immune and cardio-metabolic function: the Sun Exposure and Vitamin D Supplementation (SEDS) Study. BMC Public Health. 2015; 15: 115.

Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database of Systematic Reviews. 2014; (1).

Autier P, Gandini S. Vitamin D supplementation and total mortality : a meta- analysis of randomized controlled trials. Arch Intern Med. 2007; 167 (16): 1730- 1737.

Buchebner D, McGuigan F, Gerdhem P, Ridderstråle M, Akesson K. Association Between Hypovitaminosis D in Elderly Women and Long- and Short-Term Mortality. Results from the Osteoporotic Prospective Risk Assessment Cohort. J Am Geriatr Soc. 2016; 64 (5): 990- 7.

Barnett AG, De Looper M, Fraser JF. The seasonality in heart failure deaths and total cardiovascular deaths. Aust N Z J Public Health. 2008; 32 (5): 408- 413.

Chowdhury R, Kunutsor S, Viteziova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systemathic review and meta-analisis of observational cohort and randomised intervention studies. BMJ. 2014; 348 (5): 408- 413.

Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta – analysis of randomized controlled trials. Arch Intern Med. 2007; 167 (16): 1730- 1737.

Durup D, Jorgensen HL, Christensen J, Tjonneland A, Olsen A, Halkjaer J, Lind B, Heegaard AM, Schwarz P. A Reverse J-Shaped Association Beetween Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study. J Clin Endocrinol Metab. 2015; 100 (6): 2339- 46.

Chowdhury R, Kunutsor S, Viteziova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC et al. Vitamin D and risk of cause specific death: systemathic review and meta-analisis of observational cohort and randomised intervention studies. BMJ. 2014; 348: g 1903.

Sempos CT, Durazgo- Arvizu RA, Dawson B, Yetley EA, Looker AC, Schleicher RL, et al. Is There a Reverse J-Shaped Association Between 25-Hydroxyvitamin D and All-Cause Mortality? Results from the U.S. Nationally Representative NHANES. J Clin Endocrinol Metab. 2013; 98 (7): 3001- 3009.

Rosero O. ¿Cuándo medir y tratar la deficiencia de vitamina D en adultos? Revista ACE. 2015; 2 (2): 53- 55.

Thorne-Lyman A, Fawzi WW. Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Pediatr Perinat Epidemiol. 2012; 26 (Supl 1): 75- 9.

Aghajafari F, Nagulesapillai T, et al. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes. BMJ. 2013; 346: f1169.

De-Regil LM, Palacios C, Lombardo LK, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2012; (2).

Benachi A, Cordier AG, Courbebaisse M, Souberbielle JC. Vitamin D and Pregnancy. Presse Med. 2013; 42 (10): 1377- 1382.

Pérez-López FR, Pasupuleti V, Mezones E, Benites VA, Thota P, Deshpande A, et al. Effect of Vit D Supplementation during Pregnancy on Maternal and Neonatal Outcomes: A Systematic Review and Meta-Analysis of Randomized controlled trials. Fertil Steril. 2015; 103 (5): 1278- 1288.

Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014; 9 (11): e11265.

Bischoff H, Willett W, Wong J, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation. JAMA; 2005; 293 (18); 2257- 2264.

Ethgen O, Hiligsmann M, Burlet N, Reginster JY. Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures. Osteoporos Int. 2016; 27 (1): 301- 8.

Cashman KD, Kiely M. Towards prevention of vitamin D deficiency and beyond: knowledge gaps and research needs in vitamin D nutrition and public health. Br J Nutr. 2011; 106 (11): 1617- 27.

Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab. 2008; 93 (9): 3430- 3435.

Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, et al. Annual high-dose oral vitamin D and falls and fractures in older women. JAMA 2010; 303 (18): 1815- 1822.

Rabenda V, Bruyère O, Reginster JY. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporos Int. 2011; 22 (3): 893- 901.

Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014; 4.

Beaudart Ch, Buckinx F, Rabenda V, Gillain S, Cavalier E, Reginster JY, et al. The effects of vitamin D on skeletal muscle strength muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014; 99 (11): 433645.

Holick MF, Wacker M. Review Vitamin D—Effects on Skeletal and Extraskeletal Health and the Need for Supplementation. Nutrients. 2013; 5 (1): 111- 148.

Bischoff H, Dawson-Hughes B, Baron JA, Burckhardt P, Li R, Spiegelman D, et al. Calcium intake and hip fracture risk in men a women: a meta-analysis of prospective cohort study and randomized controlled trial. Am J Clin Nutr. 2007; 86 (6): 1780- 90.

Heike A, Bischoff F, Walter C, Willett E, Lips P, et al. A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention. N Engl J Med. 2012; 367: 40- 49.

Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM et al. Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011; 96 (10): 2997- 3006.

Abbas AK, Lichtman AH, Pillai S. Immunologic tolerance and autoimmunity. In Cellular and molecular Immunology. En Abbas AK., et al. 8va Ed. Filadelfia: Elsevier Saunders: 2016; 315- 38.

Girgis CM, Clifton-Bligh RJ, Hamrich MW, Hollinck MF, Gunton JE. The Roles of Vitamin D in Skeletal Muscle: Form, Function, and Metabolism. Endocr Rev. 2013; 34 (1): 33- 83.

Cutolo M. Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis. Ann Rheum Dis. 2013; 72 (4): 473- 75.

Muir SW, Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2011; 59 (12): 2291- 300.

Yoshimura N, Muraki S, Oka H, Nakamura K, Kawaguchi H, Tanaka S. Serum levels of 25-hydroxyvitamin D and the occurrence of musculoskeletal diseases: a 3-year follow-up to the road study. Osteoporos Int. 2015; 26 (1): 151- 61.

Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W, et al. Effect of Vitamin D Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients With Symptomatic Knee Osteoarthritis A Randomized Clinical Trial. JAMA. 2016; 315 (10): 1005- 1013.

Dong JY, Zhang WG, Chen JJ, Zhang ZL, Han SF, Qin LQ. Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients. 2013; 5 (9): 3551- 62.

Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: a metaanalysis of randomized controlled trials. Lipids Health Dis. 2012; 11: 42.

Durup D, Jorgensen HL, Christensen J, Tjonneland A, Olsen A, Halkjaer J, et al. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study. J Clin Endocrinol Metab. 2015; 100 (6): 2339- 46.

Zittermann A, Schleithoff SS, Koerfer R. Puting cardiovascular disease and vitamin D Insufficiency into perspective. Br J Nutr. 2005; 94 (4): 483- 92.

Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;

(4): 503- 511.

Vaidya A, Forman JP. Vitamina D and Hypertension: Current evidence and future directions. Hypertension. 2010; 56 (5): 774- 9.

Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D Supplementation improves cytokine profiles in patients with congestive heart failure: A Double – blind, randomized , placebo- controlled trial. Am J Clin Nutr. 2006; 83 (4): 754- 759.

Witte KK, Byrom R, Gierula J, Paton MF, Jamil HA, Lowry JE, et al. Effects of Vitamina D on Cardiac Function in Patients with Chronic HF: The VINDICATE Study. J Am Coll Cardiol. 2016; 67 (22): 2593- 603.

Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012; 33 (1): 159- 71.

Mammen AL. Statin-associated autoinmune myopathy. N Engl J Med. 2016; 374 (7): 664- 669.

Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP, Rysz J, Muntner P, Toth PP, et al; Analysis of Vit D levels in patients with and without statin –associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients. Int J Cardiol. 2015; 178: 111- 116.

Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014; 14: 4

Buchebner D, McGuigan F, Gerdhem P, Ridderstråle M, Akesson K. Association Between Hypovitaminosis D in Elderly Women and Long- and Short-Term Mortality. Results from the Osteoporotic Prospective Risk Assessment Cohort. J Am Geriatr Soc. 2016; 64 (5): 990- 7.

Chowdhury R, Kunutsor S, Viteziova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC et al. Vitamin D and risk of cause specific death: systemathic review and meta-analisis of observational cohort and randomized intervention studies. BMJ. 2014; 348: g 1903.

Rosero O. Vitamina D y Salud ósea en la mujer postmenopáusica. Revisión. Revista ACE. 2015;

(1): 14- 9.

Grundmann VH, von Versen F. Vitamin D roles in womens reproductive health? Reproductive Biology and Endocrinology. 2011; 9:146.

World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Génova: WHO: 2016; 152 pp.

Paffoni A, Ferrari S, Vigano P, Pagliardini L, Papaleo E, Candiani M, et al. Vitamin D Deficiency and Infertility: Insights From in vitro Fertilization Cycles. J Clin Endocrinol Metab. 2014; 99 (11): e2372-6.

Grundmann M, von Versen F. Vitamine D: roles in womens reproductive health. Reproductive Biologic and Endocrinology. 2011; 9:146.

Chowdhury R, Kunutsor S, Viteziova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC et al. Vitamin D and risk of cause specific death: systemathic review and meta-analisis of observational cohort and randomised intervention studies. BMJ. 2014; 348: g 1903.

Gilaberte Y, Aguilera J, Carrascosa JM, Figueroa FL, Romaní de Gabriel J, Nagore E. Vitamina D: Evidencias y Controversias. Actas Dermosifiliogr. 2011; 102 (8): 572- 88.

Hii CS., Ferrante A. The non-genomic actions of vitamin D. Nutrients. 2016; 8 (3): 135.

Keum N, Giovannucci E. Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br J Cancer. 2014; 111 (5): 976- 80.

Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014 Oct; 144 Pt A: 138- 45.

Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004; 62 (1): 60- 5.

Cómo citar

[1]
Vásquez-Awad, D. et al. 2017. Vitamina D. Consenso colombiano de expertos. Medicina. 39, 2 (ago. 2017), 140–157.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2017-08-31

Número

Sección

Guías y Consensos